Laekna Limited

This is an early-stage study to check the safety and how the body processes two new injectable drugs, LAE103 and LAE102, for weight management. It will enroll about 104 healthy adults who are overweight or have obesity, as well as healthy postmenopausal women. Researchers will te…

This early-stage study aims to test the safety and how the body processes a new injection called LAE102. It will involve 160 healthy and overweight volunteers to see how well they tolerate different doses. The research will also gather initial information on whether the injection…

This study is testing whether adding an experimental drug called afuresertib to the standard hormone therapy fulvestrant can better control advanced breast cancer that has grown despite prior treatments. It is for adults with a specific type of breast cancer (HR+/HER2-) that has …